Skip to main content Accessibility help
×
×
Home

Trade-off between the conflicting planning goals in correlation with patient’s anatomical parameters for intensity-modulated radiotherapy of prostate cancer patients

  • Amin Banaei (a1), Bijan Hashemi (a1), Mohsen Bakhshandeh (a2) and Bahram Mofid (a3)
Abstract
Aim

To quantify the relationship between the planning target volume (PTV) dose homogeneity and organs at risk (OARs) sparing in correlation with anatomical parameters in prostate intensity-modulated radiotherapy (IMRT).

Materials and methods

Nine IMRT plans with various target dose constraints’ priorities were created for 15 prostate cancer patients. Selected PTV and OARs parameters were calculated for the patients. A trade-off was assessed between homogeneity index (HI) and OAR sparing. Several anatomical parameters were evaluated to investigate their effects on the OAR sparing and HI.

Results

Inverse exponential relationships were found between the OAR sparing and HI (average R2 of 0·983 and 0·994 for bladder and rectum, respectively). Decreasing the priority led to more OARs sparing (normal tissue complication probability reduction: 97·6 and 74·5%; mean dose reduction: 16·3 and 11·3% for bladder and rectum, respectively) and worsening of the HI (0·095–0·322) but with no significant effect on tumour control probability. Furthermore, OARs volumes, distances between OARs and PTV and their joint volumes had stronger correlations with OARs’ mean doses.

Conclusion

Enforcement of target dose constraints was more effective on the improvement of HIs for the patients with initial high HI values at low dose constraints’ priorities. Reducing the priority had more effects on the OARs sparing compared to HI, especially for the patients with high OAR doses in high priority plans. This can be attributed to smaller distances or greater joint volumes between the OARs and PTV.

Copyright
Corresponding author
Author for correspondence: Bijan Hashemi, Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Al-Ahmad and Chamran Cross, Tehran 1411713116, Iran. Tel: +98-21-82883892. Fax: +98-21-88006544. E-mail: bhashemi@modares.ac.ir
Footnotes
Hide All

Cite this article: Banaei A, Hashemi B, Bakhshandeh M, Mofid B. (2019). Trade-off between the conflicting planning goals in correlation with patient’s anatomical parameters for intensity-modulated radiotherapy of prostate cancer patients. Journal of Radiotherapy in Practice page 1 of 7. doi: 10.1017/S1460396919000025

Footnotes
References
Hide All
1. Tanaka, H, Yamaguchi, T, Hachiya, K. et al. Treatment outcomes and late toxicities of intensity-modulated radiation therapy for 1091 Japanese patients with localized prostate cancer. Rep Pract Oncol Radiother 2018; 23 (1): 2833.
2. Halperin, EC, Brady, LW, Perez, CA. Perez & Brady’s principles and practice of radiation oncology, 6th edition. Philadelphia, USA: Lippincott Williams & Wilkins, 2013.
3. Nelms, BE, Robinson, G, Markham, J et al. Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems. Pract Radiat Oncol 2012; 2 (4): 296305.
4. Sun, L, Smith, W, Ghose, A, Kirkby, C. A quantitative assessment of the consequences of allowing dose heterogeneity in prostate radiation therapy planning. J Appl Clin Med Phys 2018; 19: 580590.
5. Craft, D, Khan, F, Young, M, Bortfeld, T. The price of target dose uniformity. Int J Radiat Oncol Biol Phys 2016; 96: 913914.
6. Matzinger, O, Poortmans, P, Giraud, JY et al. Quality assurance in the22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review. Radiother Oncol. 2009; 90 (3): 285290.
7. Pollack, A, Walker, G, Horwitz, EM et al. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol 2013; 31 (31): 38603868.
8. Pollack, A, Hanlon, AL, Horwitz, EM et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2006; 64 (2): 518526.
9. International Commission on Radiation Units and Measurements. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. J ICRU, Bethesda, MD, 1993; 21(November): 357–360.
10. International Commission on Radiation Units and Measurements. ICRU Report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). J ICRU Bethesda, MD, 1999.
11. International Commission on Radiation Units and Measurements. ICRU Report 83. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU, 2010;10(1).
12. Tol, JP, Dahele, M, Doornaert, P et al. Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneity. Med Phys 2014; 41 (2): 021722.
13. Craft, D, McQuaid, D, Wala, J, Chen, W, Salari, E, Bortfeld, T. Multicriteria VMAT optimization. Med Phys 2012; 39 (2): 686696.
14. Paddick, I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. J. Neurosurg 2000; 93 (Suppl 3): 219222.
15. Emami, B, Lyman, J, Brown, A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21 (1): 109122.
16. Milano, MT, Constine, LS, Okunieff, P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol. 2007; 17 (2): 131140.
17. Niemierko, A, Goitein, M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol. 1993; 29: 140147.
18. Gay, HA, Niemierko, A. A free program for calculating EUD‐based NTCP and TCP in external beam radiotherapy. Phys Med. 2007; 23: 115125.
19. Wall, PD, Carver, RL, Fontenot, JD. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer. Phys Med Biol 2018; 63 (1): 015035.
20. Landoni, V, Fiorino, C, Cozzarini, C, Sanguineti, G, Valdagni, R, Rancati, T. Predicting toxicity in radiotherapy for prostate cancer. Phys Med. 2016; 32: 521532.
21. Goitein, M. Causes and consequences of inhomogeneous dose distributions in radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12: 701704.
22. Nielsen, TB, Hansen, O, Schytte, T, Brink, C. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose. Acta Oncol. 2014; 53: 119125.
23. Balderson, MJ, Kirkby, C. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity. Int J Radiat Biol 2015; 91: 5461.
24. Mavroidis, P, Komisopoulos, G, Buckey, C et al. Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols. Phys Medica Eur J Med Phys 2017; 40: 3341.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Radiotherapy in Practice
  • ISSN: 1460-3969
  • EISSN: 1467-1131
  • URL: /core/journals/journal-of-radiotherapy-in-practice
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed